Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101
Journal of Clinical Oncology - United States
doi 10.1200/jco.2010.29.7978
Full Text
Open PDFAbstract
Available in full text
Date
October 10, 2010
Authors
Publisher
American Society of Clinical Oncology (ASCO)